Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TOMPKINS FINANCIAL CORP Director's Dealing 2018

Jul 30, 2018

32217_dirs_2018-07-30_8c528a2c-b977-4114-b1ea-d3b86a1d7e14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TOMPKINS FINANCIAL CORP (TMP)
CIK: 0001005817
Period of Report: 2018-05-29

Reporting Person: HARTZ GREGORY J (EVP, Pres.&CEO Tompkins Trust)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-29 Common Stock G 118 $84.24 Disposed 19718.525 Direct
2018-07-27 Common Stock M 519 $40.60 Acquired 20237.532 Direct
2018-07-27 Common Stock F 354 $87.23 Disposed 19883.532 Direct
2018-07-27 Common Stock M 591 $49.22 Acquired 20474.532 Direct
2018-07-27 Common Stock F 438 $87.23 Disposed 20036.532 Direct
2018-07-27 Common Stock M 379 $56.29 Acquired 20415.532 Direct
2018-07-27 Common Stock F 299 $87.23 Disposed 20116.532 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-07-27 Stock Appreciation Rights (SAR) $40.60 M 519 Disposed 2023-05-03 Common Stock (519) Direct
2018-07-27 Stock Appreciation Rights (SAR) $49.22 M 591 Disposed 2024-11-21 Common Stock (591) Direct
2018-07-27 Stock Appreciation Rights (SAR) $56.29 M 379 Disposed 2025-11-04 Common Stock (379) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4116.824 Indirect
Common Stock 2614.955 Indirect

Footnotes

F1: Bona fide gift to Charitable Gift Account

F2: Shares withheld for Option cost and taxes

F3: Includes shares acquired through reinvestment of quarterly dividends.

F4: Includes shares acquired through profit sharing or 401K contributions.

F5: Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.